Cytek Biosciences, Inc. financial data

Symbol
CTKB on Nasdaq
Location
47215 Lakeview Boulevard, Fremont, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 571 % -19.8%
Quick Ratio 68.4 % -34.5%
Debt-to-equity 27.8 % +10.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 127M shares -3.26%
Common Stock, Shares, Outstanding 127M shares -3.29%
Common Stock, Value, Issued 127K USD -3.79%
Weighted Average Number of Shares Outstanding, Basic 127M shares -3.43%
Weighted Average Number of Shares Outstanding, Diluted 127M shares -3.43%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 196M USD -0.85%
Research and Development Expense 38.2M USD -8.8%
Selling and Marketing Expense 48.9M USD +1.03%
General and Administrative Expense 46.4M USD +5.05%
Operating Income (Loss) -26.9M USD -4.04%
Nonoperating Income (Expense) 19.3M USD +102%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.56M USD +53.5%
Income Tax Expense (Benefit) -1.16M USD -189%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 75.5M USD -57.6%
Accounts Receivable, after Allowance for Credit Loss, Current 56.2M USD +26%
Inventory, Net 49.5M USD -1.16%
Other Assets, Current 2.76M USD +44.7%
Assets, Current 383M USD -0.33%
Property, Plant and Equipment, Net 18.4M USD +1.31%
Operating Lease, Right-of-Use Asset 16.4M USD +75.7%
Intangible Assets, Net (Excluding Goodwill) 18.6M USD -13.2%
Goodwill 16.7M USD +3.24%
Other Assets, Noncurrent 4.68M USD -4.82%
Assets 493M USD +1.98%
Accrued Liabilities, Current 21.6M USD +39.5%
Contract with Customer, Liability, Current 28.1M USD -26%
Liabilities, Current 73.3M USD +39.9%
Contract with Customer, Liability, Noncurrent 16.6M USD
Operating Lease, Liability, Noncurrent 14.1M USD +74%
Other Liabilities, Noncurrent 2.48M USD +37.5%
Liabilities 116M USD +22.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -38K USD +80.5%
Retained Earnings (Accumulated Deficit) -52.2M USD -14%
Stockholders' Equity Attributable to Parent 378M USD -2.97%
Liabilities and Equity 493M USD +1.98%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 127M shares -3.29%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 75.5M USD -57.6%
Operating Lease, Liability 17.4M USD +65.8%
Depreciation 3.7M USD +8.82%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -6.25M USD +60.9%
Lessee, Operating Lease, Liability, to be Paid 22.1M USD +98.4%
Property, Plant and Equipment, Gross 29M USD +15.5%
Operating Lease, Liability, Current 3.33M USD +38.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.64M USD +45.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.38M USD +32.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +74.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.63M USD +664%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.2M USD +38.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.54M USD -25%
Additional Paid in Capital 430M USD -1.22%
Amortization of Intangible Assets 3.7M USD +5.71%
Share-based Payment Arrangement, Expense 27.5M USD +13.5%